Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Hospitals' Attitudes toward Health Foods Vary: Survey
April 4, 2005
- Gov't Approves 3-year Plan for Regulatory Reform
April 4, 2005
- DIAGNOSTIC NEWS IN BRIEF
April 4, 2005
- Korosho to Relax Approval Requirements for Combination Drugs
April 4, 2005
- The Reporter's Eye: 2
April 4, 2005
- Recommendation on Use of Iressa Compiled
April 4, 2005
- OTC NEWS IN BRIEF
April 4, 2005
- Chugai's Actemra, Actelion's Tracleer to Be Approved in April
April 4, 2005
- MEDICAL DEVICE NEWS IN BRIEF
April 4, 2005
- Korosho to Prepare GL on Use of Pharmacogenomics
April 4, 2005
- Eli Lilly Japan Aiming for \250 Bil. Sales in 2015 with 3% Market Share: Mr Crenshaw
April 4, 2005
- Improve Quality Assurance through Strong Partnerships: Dr Kodato of Tanabe Seiyaku
April 4, 2005
- Astellas Aims at \50 Bil. Sales for Micardis
April 4, 2005
- REGULATORY NEWS IN BRIEF
April 4, 2005
- MPC to Market Zione with Caution
April 4, 2005
- JPMA
April 4, 2005
- Janssen Pharm. Posts Strong Growth in 2004
April 4, 2005
- BI Extends Collaboration with MorphoSys AG
April 4, 2005
- Meiji Yakuhin Completes New Contract Mfg Plant
April 4, 2005
- Alfresa HD Aims at Sales of \1,385 Bil. in 2008
April 4, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…